Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Maternal Docosa-Hexaenoic Acid (DHA) Supplementation and Offspring Neurodevelopment in India (DHANI-2)

NCT03072277 is registered in ClinicalTrials.gov with Public Health Foundation of India as lead sponsor.

NCT NCT03072277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03072277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Maternal Docosa-Hexaenoic Acid (DHA) Supplementation and Offspring Neurodevelopment in India (DHANI-2)
Lead sponsor
Public Health Foundation of India
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2015
Completion date
December 31, 2020
Enrollment
957 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pregnancy